Treatment of acute rejection with anti-T-cell antigen receptor complex αβ (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: Results of a prospective randomized double-blind trial

T. H. Waid, B. A. Lucas, J. S. Thompson, L. C. Munch, S. Brown, R. Kryscio, R. Prebeck, M. A. VanHoy, D. Jezek

Producción científica: Article › revisión exhaustiva

21 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Treatment of acute rejection with anti-T-cell antigen receptor complex αβ (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: Results of a prospective randomized double-blind trial'. En conjunto forman una huella única.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science